NBT Bank’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $35.7K | Buy |
284
+35
| +14% | +$4.4K | ﹤0.01% | 535 |
|
|
2025
Q1 | $34.1K | Sell |
249
-441
| -64% | -$60.3K | ﹤0.01% | 528 |
|
|
2024
Q4 | $106K | Buy |
690
+25
| +4% | +$3.82K | 0.01% | 419 |
|
|
2024
Q3 | $129K | Buy |
+665
| New | +$129K | 0.01% | 412 |
|
|
2023
Q3 | – | Sell |
-829
| Closed | -$236K | – | 313 |
|
|
2023
Q2 | $236K | Buy |
829
+54
| +7% | +$15.4K | 0.03% | 237 |
|
|
2023
Q1 | $215K | Sell |
775
-129
| -14% | -$35.9K | 0.03% | 241 |
|
|
2022
Q4 | $250K | Hold |
904
| – | – | 0.04% | 222 |
|
|
2022
Q3 | $241K | Buy |
+904
| New | +$241K | 0.04% | 207 |
|
|
2021
Q4 | – | Sell |
-905
| Closed | -$256K | – | 248 |
|
|
2021
Q3 | $256K | Sell |
905
-25
| -3% | -$7.07K | 0.04% | 220 |
|
|
2021
Q2 | $322K | Hold |
930
| – | – | 0.04% | 200 |
|
|
2021
Q1 | $260K | Buy |
930
+40
| +4% | +$11.2K | 0.04% | 208 |
|
|
2020
Q4 | $218K | Buy |
+890
| New | +$218K | 0.03% | 214 |
|
|
2020
Q2 | – | Sell |
-769
| Closed | -$243K | – | 213 |
|
|
2020
Q1 | $243K | Buy |
769
+80
| +12% | +$25.3K | 0.05% | 185 |
|
|
2019
Q4 | $205K | Buy |
+689
| New | +$205K | 0.03% | 219 |
|
|
2019
Q3 | – | Sell |
-879
| Closed | -$205K | – | 191 |
|
|
2019
Q2 | $205K | Hold |
879
| – | – | 0.04% | 184 |
|
|
2019
Q1 | $208K | Sell |
879
-180
| -17% | -$42.6K | 0.04% | 178 |
|
|
2018
Q4 | $319K | Sell |
1,059
-104
| -9% | -$31.3K | 0.05% | 163 |
|
|
2018
Q3 | $411K | Hold |
1,163
| – | – | 0.07% | 152 |
|
|
2018
Q2 | $337K | Hold |
1,163
| – | – | 0.06% | 155 |
|
|
2018
Q1 | $319K | Sell |
1,163
-3,492
| -75% | -$958K | 0.05% | 164 |
|
|
2017
Q4 | $1.48M | Sell |
4,655
-214
| -4% | -$68.2K | 0.23% | 99 |
|
|
2017
Q3 | $1.52M | Buy |
4,869
+4,050
| +495% | +$1.27M | 0.24% | 99 |
|
|
2017
Q2 | $222K | Hold |
819
| – | – | 0.04% | 190 |
|
|
2017
Q1 | $224K | Buy |
819
+40
| +5% | +$10.9K | 0.04% | 195 |
|
|
2016
Q4 | $221K | Buy |
779
+20
| +3% | +$5.67K | 0.04% | 190 |
|
|
2016
Q3 | $237K | Buy |
+759
| New | +$237K | 0.04% | 189 |
|